Longaeva Partners’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.6M Buy
+453,687
New +$15.9M 0.3% 84

Other funds holding VERA

Longaeva Partners's VERA Position: Q3 2026 in Review

Longaeva Partners opened a new position in Vera Therapeutics (VERA) in Q3 2026: 453,687 shares worth $14.6M. The stake represents 0.3% of the portfolio and ranks #84 among its holdings.

222 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Longaeva Partners held 453,687 shares of Vera Therapeutics worth $14.6M as of Q3 2026.
  • Vera Therapeutics was a new Longaeva Partners position in Q3 2026.
  • Vera Therapeutics made up 0.3% of Longaeva Partners's portfolio in Q3 2026, its #84 holding.
  • 222 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.